Joshua Schein
Pharma
Redhill Biopharma
Israel
Biography
Dr. Schein, based in New York, has been involved in the founding, financing and managing of pharmaceutical companies since 1991, including Lev Pharmaceuticals which was acquired by ViroPharma (NASDAQ:VPHM) for $443 million. Dr. Schein has held senior executive positions in US companies, serving as CEO of SIGA Technologies (NASDAQ: SIGA) and Lev Pharmaceuticals. Dr. Schein, based in New York, has been involved in the founding, financing and managing of pharmaceutical companies since 1991, including Lev Pharmaceuticals which was acquired by ViroPharma (NASDAQ:VPHM) for $443 million. Dr. Schein has held senior executive positions in US companies, serving as CEO of SIGA Technologies (NASDAQ: SIGA) and Lev Pharmaceuticals.
Research Interest
Pharma
